SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1119from Washington post .... a small piece of .... an extraordinary article that John McCarthy-1/12/2003
1118At H&Q, Forest Labs said they expected to hear back from the FDA in FebruaryJMarcus-1/7/2003
1117NEW YORK, Dec. 20 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRXnigel bates-12/20/2002
1116IMS Health Canada - Year-End Data Confirm Anticipated Diabetes Pandemic Experts John McCarthy-12/18/2002
1115IMS Statistics for Alzheimer Awareness Month, January MONTREAL, Dec. 18 /CNJohn McCarthy-12/18/2002
1114DJ Neurobiological Tech/Memantine -2:To Refile NDA By Yr End RICHMOND, Calif. jayhawk969-12/10/2002
1113>>NEW YORK, Dec. 9 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYtuck-12/9/2002
1112At the stockholders meeting Paul Freiman said that hCRF could help reduce brain JMarcus-11/30/2002
11112002 - [Investor Information Update] Message 18287329 John McCarthyJohn McCarthy-11/30/2002
1110A question about Xerecept.... this was posted by TabWriter on yahoo a couple ofJohn McCarthy-11/29/2002
1109Could someone explain this .... I don't get it *Why* and *what* were they John McCarthy-11/29/2002
1108nig no other way to say this - I am scared shitless about diabetic ... and hJohn McCarthy-11/29/2002
1107It's the "if" that worries me. Not at this level, of course, but nigel bates-11/29/2002
1106I'm locked into waiting for the Diabetic results .... so I really don'tJohn McCarthy-11/27/2002
1105I lucked into a few of these a couple of months back. Do you have any feel for nigel bates-11/27/2002
1104Hi Marc - thanks for posting ..... As before, I am going to copy over to the YaJohn McCarthy-11/20/2002
1103Ron Garren has climbed on-board, posting this on www.biospace.com (click on linkJMarcus-11/20/2002
1102Healthy Market Share Predicted for Memantine in the Alzheimer's Disease DrugJohn McCarthy-11/18/2002
1101mind? Not at all. I'm flattered. MarcJMarcus-11/15/2002
1100Marc - if you don't mind I'm gonna link it over to Yahoo for the troopsJohn McCarthy-11/15/2002
1099I haven't missed an NTII shareholders meeting since 1998. Here are my notesJMarcus-11/15/2002
1098RICHMOND, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Neurobiological Technologiesnigel bates-11/13/2002
1097A double-blind, placebo-controlled multicentre study of memantine in mild to modJohn McCarthy-11/2/2002
1096Forest plans to present data from a recently-completed Phase III trial of its AlJohn McCarthy-11/2/2002
1095Ordering Ebixa <<<<<<<<<<<<<<<<John McCarthy-10/8/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News